dc.contributor.author | Tornin Cavielles, Juan | |
dc.contributor.author | Martínez Cruzado, Lucía | |
dc.contributor.author | Santos Duque, Laura | |
dc.contributor.author | Rodríguez García, Aida | |
dc.contributor.author | Núñez González, Luz Elena | |
dc.contributor.author | Oro Carbajosa, Patricia | |
dc.contributor.author | Allonca Campa, Eva | |
dc.contributor.author | Astudillo González, María Aurora | |
dc.contributor.author | Suárez Nieto, Carlos | |
dc.contributor.author | Rodríguez González, René | |
dc.date.accessioned | 2017-02-01T07:39:43Z | |
dc.date.available | 2017-02-01T07:39:43Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Oncotarget, 7(21), p. 30935-30950 (2016); doi:10.18632/oncotarget.8817 | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.uri | http://hdl.handle.net/10651/39525 | |
dc.description.sponsorship | This work was supported by the Plan Nacional 2008-2011 de I+D+i [ISC III/FEDER (Miguel Servet Program CP11/00024)], the Plan Nacional de I+D+i 2013-2016 [MINECO/FEDER (SAF-2013-42946-R)], the Grupo Español de Investigación en Sarcomas (GEIS; beca J.M. Buesa-2012) and the Gobierno de Asturias (COF13-007) to R.R; and the Plan Nacional de I+D+i 2008-2011 [ISC III/FEDER RTICC (RD12/0036/0015)] and the Plan de Ciencia Tecnología e Innovación del Principado de Asturias (GRUPIN14-003) to C.S. | |
dc.description.statementofresponsibility | Tornin, J., Martinez-Cruzado, L., Santos, L., Rodriguez, A., Núñez, L.E., Oro, P., Hermosilla, M.A., Allonca, E., Fernández-García, M.T., Astudillo, A., Suarez, C., Morís, F., Rodriguez, R. | |
dc.format.extent | p. 30935-30950 | |
dc.language.iso | eng | |
dc.relation.ispartof | Oncotarget | |
dc.rights | © 2016 Juan Tornín Cavielles et al. | |
dc.rights | CC Reconocimiento 3.0 España | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971504857&partnerID=40&md5=c4ee0e39ae095c268ae2d913a83bc3d3 | |
dc.title | Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma | |
dc.type | journal article | |
dc.identifier.doi | 10.18632/oncotarget.8817 | |
dc.relation.projectID | ISC III/FEDER/CP11/00024 | |
dc.relation.projectID | MINECO/FEDER/SAF-2013-42946-R | |
dc.relation.projectID | COF13-007 | |
dc.relation.projectID | ISCIII/FEDER/RTICC/RD12/0036/0015 | |
dc.relation.projectID | COF13-007 | |
dc.relation.projectID | GRUPIN14-003 | |
dc.relation.publisherversion | http://dx.doi.org/10.18632/oncotarget.8817 | |
dc.rights.accessRights | open access | |